The New Jersey Department of the Treasury, Division of Purchase and Property, is accepting electronic quotes through NJSTART for T1683, Independent Health Care Appeals Program: Independent Utilization Review Organization, DOBI, Bid No. 26DPP01227. The New Jersey Department of Banking and Insurance uses contracted Independent Utilization Review Organizations to perform preliminary and full independent external reviews of adverse health-plan benefit determinations.
Bid Amendment #4 establishes the current quote deadline as October 6, 2026 at 2:00 p.m., submitted electronically through NJSTART. The controlling amendment does not expressly state a timezone. The NJSTART record identifies a contract term of January 1, 2027 through December 31, 2029, requires bidder pricing on the State-supplied price sheet, and includes SBE and DVOB subcontracting set-aside requirements. No bid bond or performance bond is listed.
The solicitation package includes the bid solicitation, State standard terms, standard procurement forms, a third-party information-security questionnaire, the revised State-supplied price sheet, pre-quote materials, and four posted amendments. Amendment #4 also includes responses to electronic questions and a revised bid solicitation dated September 15, 2026. Prospective bidders must rely on those controlling materials for final licensing, professional qualifications, staffing, utilization-review, security, pricing, insurance, and compliance requirements.
Atlas assessment: Atlas Opportunity Score 84/100. N9+ Fit Score 0/100. This is a clinically consequential health-services procurement, but the verified scope is independent utilization review and health-insurance appeals rather than remote physical-examination technology. Dr. Miltie/QC Healthcare direct-prime eligibility and IURO qualification are not established, so no direct submission is being advanced.